Related Experiment Video
Updated: Aug 15, 2026
Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
The effect of serum from multiple sclerosis patients in remission on the incubated rat brain slices
Abstract:
Addition of human serum to incubated rat cerebral slices induced increased generation of myelin-related, membranous fragments floating on 0.32 M sucrose. Sera from 20 healthy subjects and 19 patients with various neurological disorders were equally active in this respect. On the other hand, the myelin-degrading activity of sera from 20 multiple sclerosis patients in remission was found to be significantly elevated by about 50%. The present findings support the contention that the serum of multiple sclerosis patients possesses increased potency to induce myelin sheath alterations.
Insights
Human serum can damage myelin, the protective sheath around nerve cells. Multiple sclerosis (MS) patients' serum shows significantly higher myelin-degrading activity, suggesting a role in MS progression.
Area of Science:
- Neuroscience
- Immunology
- Biochemistry
Background:
- Myelin sheath damage is a hallmark of neurological disorders.
- Serum components may influence myelin integrity.
Purpose of the Study:
- To investigate the effect of human serum on myelin.
- To compare myelin-degrading activity in healthy individuals, patients with neurological disorders, and multiple sclerosis patients.
Main Methods:
- Incubation of rat cerebral slices with human serum.
- Quantification of myelin-related fragments in sucrose solution.
Main Results:
- Human serum induced myelin-related fragment generation.
- Sera from healthy subjects and patients with various neurological disorders showed similar activity.
- Sera from multiple sclerosis patients in remission exhibited a 50% increase in myelin-degrading activity.
Conclusions:
- Human serum possesses myelin-altering capabilities.
- Elevated myelin-degrading activity in multiple sclerosis serum suggests a potential mechanism for myelin sheath damage in the disease.
